EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation

Ania Stras iD, Aleksandra Grassmann, Peter Van Campenhout, Eric Deconinck, Tamara Vanhaecke, Bart Desmedt iD

Contact Dermatitis · 2024

DOI: 10.1111/cod.14533 ↗

At a glance

Journal article in Contact Dermatitis, 2024. Written by Ania Stras and 5 co-authors. Institution: Medicines and Health Products, Sciensano, Elsene, Belgium. Major MEDLINE topics: Preservatives, Pharmaceutical, Gas Chromatography-Mass Spectrometry. Cited 2 times so far (Crossref); 58 references.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Introduction

Medical devices (MDs) have a long history of use, and come with regulatory frameworks to ensure user safety. Although topically applied MDs in the form of gels and creams might be used on damaged skin, their composition is often similar to that of cosmetic products applicable to intact skin, especially in terms of preservatives and fragrances. However, unlike cosmetics, these products are not subject to compound‐specific restrictions when used in MDs.

Objective

This study aimed to identify and quantify preservatives and fragrances in topically applied MDs and assess their safety towards the Cosmetic Regulation (EC) 1223/2009.

Method

Sixty‐nine MDs available on the EU market were subjected to previously validated liquid chromatography tandem mass spectrometry (LC–MS/MS) and gas chromatography–mass spectrometry (GC–MS) methods to identify and quantify occurring preservatives and fragrances.

Results

Findings revealed that 32% of the examined MDs did not provide comprehensive ingredient lists, leaving users uninformed about potential risks associated with product use. Furthermore, 30% of these MDs would not meet safety standards for cosmetic products and, most significantly, 13% of the analysed samples contained ingredients that are prohibited in leave‐on cosmetics.

Conclusion

Results highlight the pressing demand for more stringent requirements regarding the labelling and composition of MDs to enhance patient safety. Improved regulation and transparency can mitigate potential risks associated with the use of topically applied MDs.

Subjects

MeSH terms (MEDLINE)

Preservatives, PharmaceuticalGas Chromatography-Mass SpectrometryHumansPerfumeCosmeticsEquipment and SuppliesEuropean UnionTandem Mass SpectrometryChromatography, LiquidConsumer Product SafetyAdministration, Topical

Author keywords

Cosmetic RegulationMDRallergic contact dermatitiscontact allergycosmeticsfragrancesmedical devicespreservatives

Substances

Preservatives, PharmaceuticalPerfumeCosmetics

Authors and institutions

  • Medicines and Health Products, Sciensano, Elsene, Belgium.
  • Department In Vitro Toxicology and Dermato-Cosmetology (IVTD), Vrije Universiteit Brussel, Jette, Belgium.
  • Université Catholique de Louvain, Wolluwe-Saint-Lambert, Belgium.

ORCID profiles: Ania Stras, Bart Desmedt

Cite

APA

Stras, A., Grassmann, A., Van Campenhout, P., Deconinck, E., Vanhaecke, T., & Desmedt, B. (2024). Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation. Contact Dermatitis. https://doi.org/10.1111/cod.14533

Vancouver

Stras A, Grassmann A, Van Campenhout P, Deconinck E, Vanhaecke T, Desmedt B. Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation. Contact Dermatitis. 2024. doi:10.1111/cod.14533

BibTeX
@article{Stras2024,
  author = {Stras, Ania and Grassmann, Aleksandra and Van Campenhout, Peter and Deconinck, Eric and Vanhaecke, Tamara and Desmedt, Bart},
  title = {Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14533}
}
Start for free →